Patent details

Basic Information

Publication number:

EP3443962

PCT Application Number:

CN2017080563

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177819380

PCT Publication Number:

WO2017177962

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

QUINOLINE DERIVATIVE FOR TREATING GASTRIC CANCER

French Title of Invention:

DÉRIVÉ DE QUINOLINE POUR LE TRAITEMENT DU CANCER DE L'ESTOMAC

German Title of Invention:

CHINOLINDERIVAT ZUR BEHANDLUNG VON MAGENKREBS

SPC Number:

Dates

Filing date:

14/04/2017

Grant date:

29/03/2023

EP Publication Date:

20/02/2019

PCT Publication Date:

19/10/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/03/2023

EP B1 Publication Date:

29/03/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/04/2023

Expiration date:

14/04/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/03/2023

 

 

Name:

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Address:

No. 369 Yuzhou South Road Haizhou District, Lianyungang, Jiangsu 222062, China (CN)

Inventor

1

Name:

CHEN, Jie

Address:

China (CN)

2

Name:

HAN, Xi

Address:

China (CN)

3

Name:

WANG, Xunqiang

Address:

China (CN)

4

Name:

JIANG, Hai

Address:

China (CN)

Priority

Priority Number:

201610238157

Priority Date:

15/04/2016

Priority Country:

China (CN)

Classification

IPC classification:

A61K 31/4709; A61P 35/00; A61K 45/06; A61P 35/04;

Publication

European Patent Bulletin

Issue number:

202313

Publication date:

29/03/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages